This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend CPC

CPC September 2021 programme

Subpage Hero

.

Loading

Optimising Antithrombotic Therapy in patients with stable CVD - what are the options?

24 Sep 2021
Clinical Theatre
Optimising Antithrombotic Therapy in patients with stable CVD - what are the options?

There are many options for optimising anti thrombotic therapy (anticoagulation and antiplatelet therapy) in patients following angioplasty.  This session aims to discuss the usually antithrombotic regimes and considerations in more complex patients with co-morbidities through the use of a case studies.  We will also review considerations for optimisation of antithrombotic therapy following one year of therapy after stent implantation and discuss the relative merits of continuing an antiplatelet or adding low dose anticoagulation to aspirin.

Partners

Lead Education Partner

  • CPPE
  • Morph

 

Education Partner

  • APTUK
  • BOPA
  • BPNG
  • CMHP
  • Health Education England

 

Education Partner

  • HIVPA
  • UKRPG
  • NHS England and NHS Improvement
  • NHS Digital
  • NHSx
  • PTOC
  • GPHC

 

Education Partner

  • NPPG
  • PCPA
  • PDA
  • Pharmacist Support
  • RPUK
  • SPS

 

Education Partner

  • Soar Beyond
  • NHCA
  • UKBPA
  • UKCPA
  • PrescQIPP
  • Pharmacy Declares
  • GHP and RPS

 

Media Partner

  • C&D
  • PDA
  • PrescQIPP
  • Scottish Healthcare Review
  • Welsh Healthcare Review
  • NI Healthcare Review
  • Prescriber

 

Nominated Charity

  • Pharmacist Support

 

Newsletter Sign Up